eXoZymes Inc. Announces Proposed Securities Offering and Releases Investor Presentation
On April 10, 2026, eXoZymes Inc. filed a Form 8-K announcing the distribution of an updated Investor Presentation to potential underwriters and other offering participants. This filing is in connection with a proposed offering of the companyβs securities. eXoZymes Inc., a Nevada-based biotechnology company listed on the Nasdaq Capital Market under the symbol 'EXOZ', is classified as an emerging growth company. The presentation, included as Exhibit 99.1, provides updated corporate information intended to facilitate the proposed capital raise. The filing was signed by Fouad Nawaz, Vice President of Finance. While the document confirms the pursuit of a securities offering, it does not specify the exact size, pricing, or definitive timing of the transaction. No specific clinical trial updates or future result dates were disclosed in the summary of this regulatory event.